For many stakeholders within the healthcare industry, the world of open research is an exciting yet occasionally confusing one. At the start of this year, key industry players from across the pharma industry met in Oxford for a roundtable discussion hosted by Wiley on ‘How the pharma–publisher relationship should evolve in the new world of … Continue reading Guest post: The open road
Humanitarians working in crisis zones need real-time access to evidence. A recent study from McMaster University in Canada explored the effectiveness of Evidence Aid’s resource collections on critical decision-making
The Center for Biomedical Research Transparency (CBMRT) hosts a free 5-year Biomedical Transparency Summit (BMTS) series in the US and Europe. The goal of BMTS is to promote discussion and collaboration on transparency across the global biomedical research ecosystem
As the collection of literature and resources on the 2019 novel coronavirus outbreak increases, Evidence Aid is working to ensure links to the latest research are made discoverable
Scientific and medical publishing is becoming more open around the world, including in Japan, where open access and open science are gaining traction.
The 2020 European Meeting of the International Society for Medical Publication Professionals (ISMPP) opened with a question – in one word, “how do you feel about the future of medical publications?” Answers included “exciting”, “evolving” and “digital”.
ORCID is part of the wider digital infrastructure needed for researchers to share information on a global scale. ORCID enables transparent and trustworthy connections between researchers, their contributions, and affiliations by providing an identifier for individuals to use with their name as they engage in research, scholarship and innovation activities. The Open Pharma community is … Continue reading Guest post: ORCID adoption in the pharma community
Finding a good book to read on holiday may sometimes be a challenge. Luckily, the Open Pharma team is here to help with its shortlist of the best reads for summer 2019!
The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
At a workshop on managing conflicts of interest in medicine, Chris Winchester, CEO of Oxford PharmaGenesis and co-founder of Open Pharma, argued for openness.